Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2026 ,inter alia, to consider and approve Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company (formerly known as Bansisons Tea Industries Ltd, now Novyra Pharmachem Limited) has informed BSE that its Board of Directors meeting, originally scheduled for 18 April 2026, has been postponed to 25 April 2026. The meeting will, among other things, consider and approve the Audited Financial Results along with the Auditor's Report and certificate for unmodified opinion for the quarter and year ended 31 March 2026. The company is registered in Surat, Gujarat, and the communication is issued under SEBI Listing Regulations, 2015. The filing also highlights that the company has undergone a name change, indicating a business shift from tea to pharmaceuticals/pharmachem.
Routine administrative update — only a date change for the results announcement. The actual results (with an unmodified auditor opinion) will be the real driver of stock reaction once released on 25 April. The name change to Novyra Pharmachem signals a likely business reorientation that investors should watch in the upcoming results.